ESTHER HERRERA: Open Payments
NPI 1700523990 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 58 payments from 22 companies in 2025. Trend: 2023 $606 · 2024 $1,276 · 2025 $1,376
Food & beverage: $1,376
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $148 |
| GlaxoSmithKline, LLC. | 8 | $136 |
| PFIZER INC. | 5 | $131 |
| Novartis Pharmaceuticals Corporation | 4 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| Lilly USA, LLC | 4 | $84 |
| Edwards Lifesciences Corporation | 2 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
Products named: JARDIANCE, LEQVIO, NURTEC ODT, SAPIEN 3 Ultra RESILIA, Adempas, TRELEGY ELLIPTA, GEMTESA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
